Boehringer Ingelheim Vetmedica, Inc.
3902 Gene Field Road
St. Joseph, Missouri 64506
- Phone 800-325-9167
Research project facilitates studies to lay a foundation for the future thanks to $200,000 donation by Prascend (pergolide mesylate), manufactured by Boehringer Ingelheim Vetmedica.
Also announced at the AAEP’s 57th Annual Convention was the donation of $200,000 to the AAEP Foundation for support of the first study - Case-Control Study of Pasture or Endocrinopathy Laminitis supported by Prascend (pergolide mesylate), manufactured by Boehringer Ingelheim Vetmedica.
“This project is in response to AAEP members prioritizing laminitis as the most important disease requiring research,” said Wayne McIlwraith, BVSc, PhD, FRCVS. “We are fortunate and very grateful our long-time industry partner Boehringer Ingelheim Vetmedica, Inc. and their new exciting product Prascend is willing to support research to help us help horses with this devastating disease.”
Laminitis remains one of the most frustrating and devastating diseases confronted by equine practitioners. The disease, which has the potential to cripple horses beyond repair, damages the critical laminae structures in the equine foot and has a variety of causes and symptoms.
"Boehringer Ingelheim Vetmedica, Inc. (BIVI) is very pleased to fund this continued research on equine laminitis," says Dr. Jane Smith, director, BIVI equine division. "We truly value the work of AAEP and their Foundation and are proud to partner with them in this research effort."
The Case-Control Study of Pasture or Endocrinopathy Laminitis is already underway under the direction of recognized epidemiologist, Noah Cohen, VMD, PhD at theTexas A&M University College of Veterinary Medicine.
Through the Laminitis Research Project, top equine researchers, AAEP members and horse owners will work together to lay a foundation for the future of laminitis research. With new information about nature of this disease, the AAEP Foundation intends to equip equine practitioners with the ability to prevent and treat horses diagnosed with laminitis.
Veterinarians and horse owners are encouraged to join the effort to eradicate laminitis through their active involvement with the Laminitis Research Project. Horses that are diagnosed with laminitis and have not yet received treatment may be submitted for these case-based studies. Horse owners and veterinarians can also choose to help through fundraising at their equine facility, home, business or veterinary practice.
For more information about contributing to the Laminitis Research Project, visit www.aaepfoundation.org.
The AAEP Foundation, a 501(c)(3) organization, was created in 1994 as the charitable arm of the American Association of Equine Practitioners. The AAEP Foundation’s mission is to improve the health and welfare of the horse through support of research, education, benevolence and the equine community. Since its inception, the Foundation has allocated more than $2.2 million to support its mission.